346 related articles for article (PubMed ID: 32121563)
21. Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy.
Morrison BJ; Roman JA; Luke TC; Nagabhushana N; Raviprakash K; Williams M; Sun P
J Virol Methods; 2017 Oct; 248():7-18. PubMed ID: 28624584
[TBL] [Abstract][Full Text] [Related]
22. Identification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus.
Srivastava V; Yang Z; Hung IF; Xu J; Zheng B; Zhang MY
J Virol; 2013 May; 87(10):5831-40. PubMed ID: 23487456
[TBL] [Abstract][Full Text] [Related]
23. Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine.
Cho A; Wrammert J
Curr Opin Virol; 2016 Apr; 17():110-115. PubMed ID: 27031684
[TBL] [Abstract][Full Text] [Related]
24. Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.
Jegaskanda S; Vanderven HA; Wheatley AK; Kent SJ
Hum Vaccin Immunother; 2017 Jun; 13(6):1-9. PubMed ID: 28332900
[TBL] [Abstract][Full Text] [Related]
25. Stringing Together a Universal Influenza Antibody.
Cerulli RA; Kritzer JA
Biochemistry; 2019 Apr; 58(15):1943-1944. PubMed ID: 30946571
[TBL] [Abstract][Full Text] [Related]
26. Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus.
Zhang Y; Xu C; Zhang H; Liu GD; Xue C; Cao Y
Viruses; 2019 Apr; 11(5):. PubMed ID: 31052339
[TBL] [Abstract][Full Text] [Related]
27. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
[TBL] [Abstract][Full Text] [Related]
28. Effector mechanisms of influenza-specific antibodies: neutralization and beyond.
Sicca F; Neppelenbroek S; Huckriede A
Expert Rev Vaccines; 2018 Sep; 17(9):785-795. PubMed ID: 30145912
[TBL] [Abstract][Full Text] [Related]
29. Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice.
van der Lubbe JEM; Verspuij JWA; Huizingh J; Schmit-Tillemans SPR; Tolboom JTBM; Dekking LEHA; Kwaks T; Brandenburg B; Meijberg W; Zahn RC; Roozendaal R; Kuipers H
Front Immunol; 2018; 9():2350. PubMed ID: 30369928
[TBL] [Abstract][Full Text] [Related]
30. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
[TBL] [Abstract][Full Text] [Related]
31. Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.
Leon PE; He W; Mullarkey CE; Bailey MJ; Miller MS; Krammer F; Palese P; Tan GS
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):E5944-E5951. PubMed ID: 27647907
[TBL] [Abstract][Full Text] [Related]
32. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
[TBL] [Abstract][Full Text] [Related]
33. A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA.
Bangaru S; Zhang H; Gilchuk IM; Voss TG; Irving RP; Gilchuk P; Matta P; Zhu X; Lang S; Nieusma T; Richt JA; Albrecht RA; Vanderven HA; Bombardi R; Kent SJ; Ward AB; Wilson IA; Crowe JE
Nat Commun; 2018 Jul; 9(1):2669. PubMed ID: 29991715
[TBL] [Abstract][Full Text] [Related]
34. Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection.
de Vries RD; Nieuwkoop NJ; Pronk M; de Bruin E; Leroux-Roels G; Huijskens EGW; van Binnendijk RS; Krammer F; Koopmans MPG; Rimmelzwaan GF
Vaccine; 2017 Jan; 35(2):238-247. PubMed ID: 27914742
[TBL] [Abstract][Full Text] [Related]
35. Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.
Mullarkey CE; Bailey MJ; Golubeva DA; Tan GS; Nachbagauer R; He W; Novakowski KE; Bowdish DM; Miller MS; Palese P
mBio; 2016 Oct; 7(5):. PubMed ID: 27703076
[TBL] [Abstract][Full Text] [Related]
36. Development of a universal influenza vaccine using hemagglutinin stem protein produced from Pichia pastoris.
Wang SC; Liao HY; Zhang JY; Cheng TR; Wong CH
Virology; 2019 Jan; 526():125-137. PubMed ID: 30388628
[TBL] [Abstract][Full Text] [Related]
37. Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.
Laidlaw BJ; Decman V; Ali MA; Abt MC; Wolf AI; Monticelli LA; Mozdzanowska K; Angelosanto JM; Artis D; Erikson J; Wherry EJ
PLoS Pathog; 2013 Mar; 9(3):e1003207. PubMed ID: 23516357
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
[TBL] [Abstract][Full Text] [Related]
39. A novel H6N1 virus-like particle vaccine induces long-lasting cross-clade antibody immunity against human and avian H6N1 viruses.
Yang JR; Chen CY; Kuo CY; Cheng CY; Lee MS; Cheng MC; Yang YC; Wu CY; Wu HS; Liu MT; Hsiao PW
Antiviral Res; 2016 Feb; 126():8-17. PubMed ID: 26593980
[TBL] [Abstract][Full Text] [Related]
40. Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells.
Hashimoto G; Wright PF; Karzon DT
J Infect Dis; 1983 Nov; 148(5):785-94. PubMed ID: 6605395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]